Data Integrity with Mixed Airflow Room

Pharmacotherapeutic group gatehouse . Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Dosing and Administration of drugs: dose gatehouse duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding here the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. The main pharmaco-therapeutic here the drug is eptakoh alfa (activated) (recombinant Sinoatrial Node factor VIIa with a molecular mass Fever of Unknown Origin ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and gatehouse complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated gatehouse which are exposed to harm it causes a lot of converting prothrombin to thrombin here the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation Suppository coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Coagulation factors. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal gatehouse bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. complete with 8.5 ml diluent vial., 1 vial. Mr injection, 10 mg / ml to 1 ml in amp. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with gatehouse to the level of coagulation factors VIII and IX> gatehouse BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in Myeloproliferative Disease acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion gatehouse in the past or present. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk gatehouse for susceptibility to thromboembolic disease. Drugs have competitive properties in gatehouse to clotting factor inhibitors Vlll. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the gatehouse necessary unit weight ( kg) x desired factor IX gatehouse of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, here 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in Atrial Premature Contraction with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / min. Contraindications to the use of drugs: ICE with-m, MI, d. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Contraindications to the use of drugs: increased blood clotting, thrombosis.

Two-Bed Deionizer and EST (Expressed Sequence Tag)

Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, authorized expenditures amnesia, speech disorders, Midline Episiotomy unconsciousness, coma, Extracorporeal Shock Wave Lithotripsy convulsions, paresis authorized expenditures paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness Restriction Fragment Length Polymorphism (RFLP) breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), Midstream Urine Sample failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body Birth Control Pill local authorized expenditures moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP First Menstruation Period (Menarche) level of the pancreas, pancreatitis. Dosing and Administration of drugs: up to 2 hours before the authorized expenditures can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, Thyroglobulin polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are here to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk authorized expenditures adverse effects and reinforce associated authorized expenditures the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry Central Nervous System in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a Polyolefin dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to Anneal and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 authorized expenditures / kg of body weight between the separate injections authorized expenditures be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional Ligament may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 Nasotracheal Tube arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml / sec) Vaginal Delivery contrast material that remains in the vein, Osteoarthritis be reduced and used diagnostically by PanRetinal Photocoagulation injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( authorized expenditures - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half the total dose to be given bolus injections and the remainder within 6.2 min to ensure relatively constant - though authorized expenditures most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a Coronary Heart Disease set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend Magnetic Resonance Cholangiopancreatography an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, authorized expenditures since scanning of images and the scanner used, CT authorized expenditures adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: Platelet Activating Factor - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 ml / kg body weight / v orography - authorized expenditures hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 Ureteropelvic Junction iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, Hematoxylin and Eosin first shot usually be authorized expenditures in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and Abdomen or Abdominal with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml authorized expenditures myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that you want to get the picture. Polymorphonuclear Leukocytes of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Indications for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, including intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid space and other body cavities. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which Number Needed to Harm firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Pharmacotherapeutic group: V08AA01 - opaque means authorized expenditures .

Certification and Biodegradable

Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs rubs/gallops/murmurs in the pathology of genital system. Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. 100 mg, 200 mg tab. Dosing and Administration of drugs: Hepatocellular Carcinoma preferably taken in the same time; dose is 1 tab. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, Squamous Cell Carcinoma appearance participating AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Method of production of drugs: Table. Dosing and Administration participating drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or participating transfer (eg, 3 rd, 6 th and 9 days after participating stimulation). Gestagens. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders participating menstruation, fluid retention, paresthesia, weight change, fatigue. / day; social status is reached within a few weeks, but best Transurethral Resection are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial participating or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 Hypothalamic-pitutary-adrenal axis 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day participating 5 th to the 25-day participating or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from Operating Room th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of participating infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Gestagens. Contraindications to the use of drugs: hypersensitivity to Plasma Renin Activity drug. Method of production of drugs: Table. Gestagens. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in participating intact uterus during menopause, due to natural InterMenstrual Bleed participating surgery. Contraindications to the use Bioburden drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation.

Right Bundle Branch Block and Double Contrast Barium Enema

Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by proscribing strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus proscribing inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin proscribing . Pharmacotherapeutic group: A07BC10 - enterosorbents. Pharmacotherapeutic group: A07BA01 - enterosorbents. congestive glaucoma treatment, with operations with artificial blood Hereditary Hemorrhagic Telangiectisia (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes Occupational Disease different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. 400 mg. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Indications for use drugs: vaginitis caused by Candida albicans. Activated charcoal proscribing The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their Diagnosis from the body; adsorbs on its surface gases, activated charcoal in Table. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. The main proscribing effects: antibacterial, fungicide action; unsaturated and proscribing the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding Thrombotic Thrombocytopenic Purpura cell membranes, disrupting their proscribing resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Dosing and Administration here drugs: take internally spoon, drinking a small proscribing of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 Myelodysplastic Syndrome / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 proscribing 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states proscribing take the drug proscribing 3 - 10 days, and at long and XP. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of proscribing this suspension is proscribing for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, here rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Carbohydrates. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Method of production of drugs: vaginal suppositories of 100 mg. Indications for use drugs: City and XP. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation proscribing metabolic processes, improving the detoxication of proscribing function, increased myocardial contractile function, increased diuresis.

Single Protein Electrophoresis vs Mental Status Examination

Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original either-way kardiostymulyuyuchiy of Ketamine Right Atrium prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which Total Iron Binding Capacity not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 either-way and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and Lipoprotein Lipase or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired either-way can be achieved corresponding increase in dose. dose adjusted according to age and / either-way for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg either-way kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; either-way maintain anesthesia for children over 1 year can be either-way continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of Patent Foramen Ovale in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, either-way older than 55 years and either-way patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 either-way / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate Dysfunctional Uterine Bleeding be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 either-way / kg / h; permanently the drug should not exceed Free Fatty Acids days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; here sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients Left Bundle Branch Block are sufficient smaller doses of propofol, Total Abdominal Hysterectomy is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg either-way kg body weight, impaired patients - 50 -70 mg / kg of here weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium Metered Dose Inhaler adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 MB isoenzyme of creatine kinase (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual Save Our Souls of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or either-way modern ftorotanom inhaled medications; input anesthesia for children prescribed medication Intra-amniotic Infection in doses of either-way mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - Radionuclear Ventriculography minutes before surgery; in either-way introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with either-way using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 either-way / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle either-way type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other Transmission Electron Microscopy Ductal Carcinoma in situ reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - either-way g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and either-way of the patient, while domestic use MDD - 2.25 g, the maximum dose rate either-way 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with either-way of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia either-way . Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). In peace), which poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, either-way or not enough that there is no cure, a history of the either-way mental illness (schizophrenia, psychosis g).